The Beauty Health Company (NASDAQ:SKIN) Receives $7.50 Consensus Target Price from Analysts

NASDAQSKIN is a publicly traded company that operates in the beauty and health industry. The company's stock is listed on the Nasdaq Global Select Market under the ticker symbol NASDAQSKIN. According to MarketBeat Ratings, the company has received an average rating of "Reduce" from thirteen analysts covering the stock. This means that out of the thirteen analysts, ten have given a negative recommendation for the stock, while three have given a neutral recommendation and none have given a positive recommendation.

Out of these thirteen analysts, three have issued a sell recommendation for the stock, indicating that they believe the stock is overvalued and expect its price to decline in the near future. Eight analysts have given a hold recommendation, meaning they do not see any significant upside or downside potential in the stock and recommend investors to hold their positions. Two analysts have given a buy recommendation, indicating that they believe the stock is undervalued and expect its price to increase in the near future.

In addition to this information, MarketBeat Ratings also reports that NASDAQSKIN has received a consensus target price of $7.50 from analysts covering the stock. This means that out of all the analysts covering the stock, they have an average price target for the stock, which is $7.50. This indicates that analysts believe that the stock is currently trading at a discount to its intrinsic value and expect it to reach this price in the near future.

It's important to note that while analyst ratings can provide some insight into a company's performance and potential, they should not be the sole basis for investment decisions. Investors should also consider other factors such as the company's financial statements, management team, competitive landscape, and overall market conditions when making investment decisions.